Blog Post

New Treatments, Universal Screening May Ease Burden of Perinatal Depression

By | Blog Post, News

The most common, most underdiagnosed, and most undertreated pregnancy-related complication in the United States is perinatal depression — depression that occurs during pregnancy or within the first year after delivery. An estimated 10 to 20 percent of new mothers experience perinatal depression (a more inclusive term than postpartum depression), with half of these women going undiagnosed and untreated.  

Read More

SWHR Hires Sherie Lou Santos as Director of Science Policy

By | Blog Post, News, Press Release

The Society for Women’s Health Research has hired Sherie Lou Z. Santos, MPH, as director of science policy. In this role, Santos will envision, direct, and implement creative science programs and policy activities designed to improve women’s experiences in health care, as well as provide strategic insight on scientific policy challenges and opportunities for engagement.

Santos previously worked as an American Public Health Association congressional policy fellow for Sen. Patty Murray on the Senate Health, Education, Labor and Pensions Committee. Santos served as key staff on legislative negotiations, as well as advised Sen. Murray, ranking member of the committee, on Food and Drug Administration-related drug pricing and public health policies.

Prior to her fellowship, Santos was a program manager at the University of Maryland for Project HEAL (Health through Early Awareness and Learning), a five-year National Cancer Institute-funded program seeking to identify the best way to implement evidence-based strategies to increase cancer screening.

Santos is a Master Certified Health Education Specialist (MCHES) and earned her dual MPH at the Loma Linda University with concentrations in health promotion and education and maternal and child health. She received her bachelor’s degree in psychology from George Washington University. Santos is also the chair-elect of the Public Health Education and Health Promotion Section of the American Public Health Association.

SWHR Praises Work of Dedicated FDA Women’s Health Advocate Marsha Henderson

By | Blog Post, News

In her 22 years at the Food and Drug Administration, Marsha B. Henderson has had a profound influence on the advancement of women’s health research. When she retires at the end of this year, the FDA will surely feel the absence of this dedicated advocate and her leadership as FDA’s associate commissioner for women’s health and director of the Office of Women’s Health (OWH).

Read More
Social media & sharing icons powered by UltimatelySocial